Reports reveal racial and ethnic disparities in lupus rates
Two new papers reveal striking racial and ethnic disparities in the incidence and prevalence of lupus, a systemic autoimmune disease that can affect virtually any organ system. The reports, which are published in Arthritis & Rheumatology, provide the latest information from lupus registries in California and New York.
In the reports from the California Lupus Surveillance Project and the Manhattan Lupus Surveillance Program, investigators estimated the frequency of lupus in a combined 2.4 million residents living in San Francisco and Manhattan. They found a similar overall age-adjusted annual incidence of lupus of 4.6 per 100,000. The age-adjusted prevalence was slightly greater in California than Manhattan (84.8 versus 62.2 per 100,000).
Women experienced higher rates of lupus than men, and the prevalence of lupus in both Hispanics and Asians was greater than that seen in Whites, but not as frequent as Blacks. The age-standardized prevalences in women per 100,000 for the California and Manhattan registries, respectively, were 458.1 and 210.9 for Black women, 177.9 and 138.3 for Hispanic women, 149.7 and 91.2 for Asian women, and 109.8 and 64.3 for White women.
“There is a paucity of population-based studies of incidence and prevalence of lupus among Asians and Hispanics in the United States,” said University of California, San Francisco’s Maria Dall’Era, MD, lead author of the California report. “These registries were able to address this deficiency and provide contemporary epidemiological estimates.”
The findings indicate that doctors should be vigilant in looking for lupus in not only Black patients, but also in Asians and Hispanics. “Physicians should consider the diagnosis especially when patients come in with symptoms that could be consistent with lupus such as arthritis, rashes, and signs of kidney disease,” said NYU School of Medicine’s Peter Izmirly, MD, lead author of the Manhattan report. “Hopefully this can lead to earlier diagnosis of the disease and better care.”
Additional studies are needed to determine the contributions of genetic and biological factors in addition to social and environmental factors that might play a role in racial and ethnic variation in the risk of lupus. “With this information, we will better understand how to diagnose and treat lupus in affected populations with the ultimate goal of disease prevention,” said Dr. Dall’Era.
The California Lupus Surveillance Project was funded by the Centers for Disease Control and Prevention with a cooperative agreement with the California Department of Public Health. The Manhattan Lupus Surveillance Program was supported by cooperative agreements between the Centers for Disease Control and Prevention and The New York City Department of Health and Mental Hygiene.
Journalist may sign up for embargoed news or to request a copy of any study please contact:
Dawn Peters (US) +1 781-388-8408 [email protected]
Follow us on Twitter @WileyNews
“The Incidence and Prevalence of Systemic Lupus Erythematosus: The California Lupus Surveillance Project.” Maria Dall’Era, Miriam G. Cisternas, Kurt Snipes, Lisa J. Herrinton, Caroline Gordon, and Charles G. Helmick. Arthritis & Rheumatology; Published Online: September 11, 2017 (DOI: 10.1002/art.40191).
URL Upon Publication: http://doi.wiley.com/10.1002/art.40191
“The Incidence and Prevalence of Systemic Lupus Erythematous: The Manhattan Lupus Surveillance Program.” Peter M. Izmirly, Isabella Wan, Sara Sahl, Jill P. Buyon, H. Michael Belmont, Jane E. Salmon, Anca Askanase, Joan M. Bathon, Laura Geraldino-Pardilla, Yousaf Ali, Ellen M. Ginzler, Chaim Putterman, Caroline Gordon, Charles G. Helmick, and Hilary Parton. Arthritis & Rheumatology; Published Online: September 11, 2017 (DOI: 10.1002/art.40192).
URL Upon Publication: http://doi.wiley.com/10.1002/art.40192
Editorial: “Lupus the Chameleon: Many Disguises Difficult to Capture.” Susan Manzi and Joan Merrill. Arthritis & Rheumatology; Published Online: September 11, 2017 (DOI: 10.1002/art.40190).
URL Upon Publication: http://doi.wiley.com/10.1002/art.40190
For Dr. Dall’Era: UCSF’s Peter Farley, at [email protected] or +1 (415) 502-4608.
For Dr. Izmirly: NYU Langone Health’s Ryan Jaslow at [email protected] of +1 (212) 404-3511.
About the Journal
Arthritis & Rheumatology is an official journal of the American College of Rheumatology (ACR) and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization whose members share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. The journal is published by Wiley on behalf of the ACR. For more information, please visit http://wileyonlinelibrary.com/journal/art.
Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at http://www.wiley.com.